Skip to content
Screener

Bio-Rad Laboratories BIO Life Science — Depreciation, Depletion and Amortization

Other segment segments

Clinical Diagnostics
$22.6M+7.1%

Similar metrics at other companies

STERIS logo
STEHealthcare Products and Life Sciences — Depreciation, Depletion and Amortization
$81.9M-4.5%
IR
IRPrecision and Science Technologies — Depreciation, Depletion and Amortization
$64.6M+26.2%
HWK
HWKNFood and Health Sciences — Depreciation, Depletion and Amortization
$3.22M+3.1%
Daktronics logo
DAKTLive Events — Depreciation, Depletion and Amortization
$1.22M-10.9%
PROG Holdings logo
PRGFour — Depreciation, Depletion and Amortization
$253K-35.5%
Air Products and Chemicals logo
APDEurope — Depreciation, Depletion and Amortization
$72.5M+27.6%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Life ScienceClinical Diagnostics
2026$100.9$181.8
2025$100.2$179.2
2026$127.6$181.8
2025$128.4$177.6
2026$18.3$22.6
2025$17.0$21.1
2026$301.7$468.8
2025$308.1$482.0

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's life science — depreciation, depletion and amortization?
Bio-Rad Laboratories (BIO) reported life science — depreciation, depletion and amortization of $18.3M in Q1 2026.
How has Bio-Rad Laboratories's life science — depreciation, depletion and amortization changed year-over-year?
Bio-Rad Laboratories's life science — depreciation, depletion and amortization increased by 7.6% year-over-year, from $17M to $18.3M.
What is the long-term trend for Bio-Rad Laboratories's life science — depreciation, depletion and amortization?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — depreciation, depletion and amortization has grown at a 8.2% compound annual growth rate (CAGR), from $54.8M to $75M.
What does life science — depreciation, depletion and amortization mean?
The non-cash expense allocated to the Life Science segment for the systematic reduction in the value of tangible and intangible assets over their useful lives. This reflects the consumption of capital equipment and acquired technology.

Ask your AI about Bio-Rad Laboratories's life science — depreciation, depletion and amortization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude